Clinical trial
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
NCT06523582 is registered in ClinicalTrials.gov with Universidad Nacional Autonoma de Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
- Lead sponsor
- Universidad Nacional Autonoma de Mexico
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 3, 2022
- Completion date
- March 1, 2037
- Enrollment
- 750 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
carney complex, carney stratakis dyad, carney triad, cowden syndrome, dicer1 syndrome, familial isolated pituitary adenoma, gastrointestinal stromal tumors, li-fraumeni syndrome, lynch syndrome, medullary thyroid cancer, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 4, neuroendocrine neoplasm, neuroendocrine neoplasm of gastrointestinal tract, neuroendocrine neoplasm of lung, neuroendocrine tumor of pancreas, neurofibromatosis 1, paraganglioma, pheochromocytoma, pituitary tumor, primary hyperparathyroidism, thymic neuroendocrine neoplasm, tuberous sclerosis, von hippel-lindau disease, x-linked acrogigantism